Supplemental File: Tumor-infiltrating lymphocytes as a predictive biomarker of cutaneous immune-related adverse events after immune checkpoint blockade in patients with advanced melanoma
Published: 6 March 2023| Version 1 | DOI: 10.17632/bp7f6gn8ks.1
Contributors:
Michael Stephens, Maria Asdourian, Ted Jacoby, Nishi Shah, Leah Thompson, Tracey Otto, Yevgeniy Semenov, Kerry Reynolds, Ryan Sullivan, Ruth Foreman, Steven ChenDescription
This file contains additional details on study design and statistical methodology.
Files
Categories
Dermatology, Oncology, Biomarkers, Toxicity, Melanoma, Immune Checkpoint Blockade, Tumor Infiltrating Lymphocyte, Immune Checkpoint Inhibitor